Search results
Order by most recent / most popular / relevance
Results: 1-2 of 2
Game changing off-label marketing decision has implications for related securities lawsuits
- Fox Rothschild LLP
- -
- USA
- -
- December 5 2012
I previously wrote about how the Food and Drug Administration and Department of Justice used the responsible corporate officer doctrine to charge former Purdue Pharma executives and in-house counsel with criminal liability and career-ending debarment for “off-label” drug marketing, even though the charged parties did not personally participate in the conduct or even know about it
Enzyte enhances only the jail exposure of the charlatans who promoted it
- Fox Rothschild LLP
- -
- USA
- -
- January 17 2011
Over the last ten years, television viewers have been inundated with commercials starring "Smiling Bob," whose enthusiastic mien, we learn, stems from his happy experiences with Enzyte, a male performance-enhancing product
